Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anticoagulation linked to low BMD in children

Patel KN et al. Thrombosis & Hemostasis Societies of North America 2018, Poster 65.

Key clinical point: Low bone mineral density and vitamin D are not uncommon in chronically anticoagulated children.

Major finding: Of chronically anticoagulated children, 52% were vitamin D deficient and another 24% had insufficient levels of the nutrient.

Study details: A retrospective, single-center cohort study of 50 chronically anticoagulated children.

Disclosures: Dr. Patel reported having no financial disclosures.

Source: Patel KN et al. Thrombosis & Hemostasis Societies of North America 2018, Poster 65.

Read the article.

Citation:

Patel KN et al. Thrombosis & Hemostasis Societies of North America 2018, Poster 65.

This Week's Must Reads

Case studies shed light on treatment for rare form of MCL , Mori S et al. Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):e93-7.

Histopathological clues for differentiating follicular lymphomas, Servitje O et al. J Cutan Pathol. 2019;46:182-9.

Single agent daratumumab is not an option in B-cell lymphomas, Salles G et al. Clin Lymphoma Myeloma Leuk. 2019 Jan 2. doi: 10.1016/j.clml.2018.12.013.

Ibrutinib combo advances in CNS lymphoma, Grommes C et al. Blood. 2019;133(5):436-45.

Best frontline options for advanced follicular lymphoma, Shah NN et al. Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):95-102.

Must Reads in Bleeding Disorders

Durable responses for hemophilia A gene therapy, High K et al. ASH 2018, Abstract 487

A clot lysis contradiction with mild bleeding, Vries MJA et al. Thromb Res. 2018 Dec 4. doi: 10.1016/j.thromres.2018.12.004

Factor VIII inhibitors seen in some patient subgroups, not others, Gangadharan B et al. ASH 2018, Poster 3774

Could thrombin generation be a better biomarker?, Nossair F et al. ASH 2018, Poster 3788

Novoeight looks safe in hemophilia A extension trial, Lentz SR et al. Haemophilia. 2018 Nov;24(6):e391-e394